Rayence Co. Ltd

Rayence Co. Ltd

228850 · KQ · Healthcare / Medical Devices

7,350.00KRW+150.00 (+2.08%)

Price History

Full chart

Market Stats

Previous Close7,200.00
Open7,250.00
Day Range7,120.00 – 7,460.00
52-Week Range4,835.00 – 8,750.00
Volume35.11K
Market Cap133.60B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.52%
Beta0.50
50-Day Avg6,987.40
200-Day Avg6,137.13

About

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS. In addition, the company offers medical information systems for veterinary hospitals; and engages in veterinary medical device and medicine wholesale and retail business, as well as research and development of process equipment and deposition materials. Further, it is involved in import and sales of X-ray detectors, and manufacturing and sales of ISOs. Rayence Co., Ltd. was founded in 2011 and is headquartered in Hwaseong-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. YoungKwon Seo
  • Employees221
  • Headquarters14, Samsung 1-ro 1-gil, Hwaseong-si, South Korea, Korea
  • Websitehttps://www.rayence.com

Leadership

  • Mr. YoungKwon SeoInside Director & CEO · b. 1972
  • Mr. Jae-jeong SeoPresident & Executive Director · b. 1974

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue86.61B98.46B106.52B116.39B126.17B101.52B134.57B147.16B142.99B125.56B114.72B
Growth (%)-+13.68%+8.19%+9.27%+8.41%-19.54%+32.55%+9.36%-2.84%-12.18%-8.63%
Cost of Revenue48.84B58.12B65.98B71.05B75.27B64.70B79.53B84.60B85.09B77.39B73.80B
Gross Profit37.76B40.33B40.54B45.34B50.90B36.82B55.03B62.56B57.89B48.17B40.92B
Gross Margin43.60%40.97%38.06%38.95%40.34%36.27%40.90%42.51%40.49%38.36%35.67%
Operating Expense18.04B22.36B23.24B26.97B31.72B35.21B36.93B40.53B38.55B41.54B44.87B
Operating Income19.72B17.98B17.30B18.36B19.19B1.61B18.10B22.03B19.35B6.63B-3.95B
Operating Margin22.77%18.26%16.24%15.78%15.21%1.59%13.45%14.97%13.53%5.28%-3.44%
EBITDA-------31.15B28.91B18.32B1.40B
EBITDA Margin-------21.17%20.22%14.59%1.22%
Net Income14.48B14.74B14.62B15.73B14.69B-1.92B14.46B22.05B19.60B7.83B-5.28B
Net Income Margin16.72%14.98%13.73%13.51%11.64%-1.89%10.74%14.98%13.71%6.24%-4.60%
R&D-10.59B8.51B--4.78B8.17B9.33B10.79B13.73B14.70B
R&D as % of Total Revenue-10.76%7.99%--4.71%6.07%6.34%7.55%10.94%12.81%
Interest Expense00000915.89M946.06M937.16M1.26B787.66M301.15M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.90%0.70%0.64%0.88%0.63%0.26%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets94.08B190.36B196.45B201.13B232.07B224.72B241.80B262.00B277.49B269.22B261.22B
Total Liabilities34.06B24.94B19.81B19.27B37.78B36.55B41.22B37.25B36.69B24.55B23.85B
Total Equity60.02B165.42B176.64B181.86B194.30B188.17B200.58B224.75B240.22B244.40B236.96B
Cash15.75B9.09B20.74B25.98B27.48B42.45B40.20B53.23B54.15B55.02B47.52B
Total Debt16.85B5.37B4.19B-5.88B5.83B-----

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.33B8.37B20.62B14.70B9.45B23.25B20.94B16.61B25.82B24.84B9.21B
Investing Cash Flow-6.78B-95.03B-2.92B5.08B-18.56B-4.56B-20.28B1.18B-20.93B-8.32B-
Financing Cash Flow1.99B79.95B-5.74B-14.32B10.69B-3.88B-2.39B-3.62B-3.69B-17.26B-
Capital Expenditure10.22B15.26B4.86B2.59B7.18B2.49B1.91B1.91B4.34B8.36B2.34B
Free Cash Flow----5.65B15.27B18.75B14.69B21.48B16.48B6.87B
Dividends Paid--1.71B1.62B1.57B2.58B1.57B1.57B2.58B1.57B1.57B
FCF to OCF----59.81%65.67%89.55%88.44%83.19%66.33%74.61%
Dividend Paid to FCF----27.83%16.89%8.39%10.71%12.01%9.55%22.91%

Earnings

Report DateAug 12, 2016Nov 3, 2016Feb 17, 2017May 2, 2017Aug 4, 2017Nov 2, 2017Feb 14, 2018Apr 23, 2018Jul 29, 2018Nov 2, 2018Feb 1, 2019May 3, 2019Jul 31, 2019Nov 5, 2019Feb 26, 2020May 8, 2020Aug 14, 2020Nov 13, 2020Jan 28, 2021May 10, 2021Aug 9, 2021Nov 8, 2021Mar 11, 2022May 13, 2022Aug 8, 2022Nov 8, 2022Feb 15, 2023May 15, 2023Aug 8, 2023Nov 8, 2023Mar 18, 2024May 10, 2024Aug 14, 2024Nov 7, 2024Feb 17, 2025May 15, 2025Aug 19, 2025Nov 11, 2025Mar 16, 2026May 13, 2026Aug 12, 2026
EPS Estimate-290.00-258.00260.00-423.42225.78269.22-856.00-----------1161.00----1363.00--705.00-1373.00--1085.00--820.00--
EPS Actual206.00215.00289.01169.00213.00265.00238.00283.00345.00277.9966.00310.00307.00332.00-17.00292.0027.00-19.00-421.92412.00412.00221.00222.00325.00391.30432.60252.25190.00394.02505.25156.00277.08178.00102.15-59.3114.00-80.38157.07-427.00374.45161.18
Surprise--25.86%--34.50%-18.08%--43.79%25.34%28.15%--92.29%------------80.88%-----86.06%---77.87%--87.04%---98.71%---152.07%--
TimingAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-market--Pre-market-Pre-market--Pre-market--Pre-market--

Key Statistics & Ratios

Market Cap133.60B
Enterprise Value-17.26B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.01
Price / Book0.52
Revenue (TTM)131.69B
Gross Profit (TTM)49.51B
EBITDA7.89B
Profit Margin3.18%
Operating Margin6.89%
Return on Equity1.71%
Return on Assets0.94%
Shares Outstanding15.74M
Shares Float4.94M
Beta0.50
Dividend Yield3.52%
Dividend Rate300.00
Payout Ratio112.91%

Dividends

20251×
300.00Dec 29, 2025
20241×
100.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
300.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
300.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20171×
100.00Dec 27, 2017
20161×
300.00Dec 28, 2016